Impact of Low-Level Laser Therapy on Hair Regrowth Post PRP Treatment

June 24, 2025 updated by: Muhammad Naveed Babur, Superior University
Low-level laser stimulates cells in the hair follicles, which promotes hair growth. The patient's own blood platelets are used in platelet-rich plasma treatment to encourage hair growth. Combining low-level laser treatment with platelet-rich plasma will promote hair growth in patients.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

To determine the impact of low-level laser therapy on hair regrowth following prp treatment.

This will be case control study conducted on 22 participants with androgenetic alopecia (AGA).

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
      • Lahore, Pakistan
        • Reshape Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults between 18-35 years diagnosed with androgenic alopecia or other non-scarring hair loss conditions.
  • Having the Norwood-Hamilton scale placed in stages I-V for men Ludwig scale in stages I-III for women .

Exclusion Criteria:

  • Use of systemic medications (e.g., corticosteroids, immunosuppressants) or treatments affecting hair regrowth within the last 3 months.
  • History of hypersensitivity or adverse reactions to laser therapy
  • Active systemic diseases such as uncontrolled diabetes, autoimmune disorders, or malignancies
  • Pregnant or breastfeeding individuals.
  • Patients with pacemakers or implanted medical devices contraindicated with low level laser therapy.
  • History of hair transplant surgery in the treatment area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PRP treatment
Combination product: PRP treatment
PRP treatment involves drawing a blood sample, processing it to concentrate platelets, and then injecting that concentrated plasma back into the body, typically at the site of an injury or area needing regeneration. The procedure aims to utilize the growth factors within the platelets to accelerate healing and tissue repair.
Active Comparator: low leve laser therapy post prp treatment
Combination product: low level laser therapy post prp treatment
will receive low-level laser therapy post prp treatment upto 12 weeks .Low-level laser therapy (LLLT) is a non-invasive treatment for hair loss that uses low-intensity laser light to stimulate hair follicles and improve blood circulation. It's often used on its own or combined with other therapies like PRP.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physician's Global Assessment (PGA) scale
Time Frame: 12 Months
The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Superior University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 17, 2025

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

February 28, 2026

Study Registration Dates

First Submitted

June 24, 2025

First Submitted That Met QC Criteria

June 24, 2025

First Posted (Actual)

July 2, 2025

Study Record Updates

Last Update Posted (Actual)

July 2, 2025

Last Update Submitted That Met QC Criteria

June 24, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MSAHSW/Batch-Fall23/903

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Baldness

Clinical Trials on PRP treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe